[Surgery alone or in association with preoperative uterovaginal brachytherapy for stage IB1 cervical cancer: Toxicities profiles].
CONCLUSION: The present study comparing two stage-IB1 cervical cancer treatment strategies found no significant difference in early or late complications. In 2 months, there was greater grade-3 urinary toxicity (21.1%) and sexual disorder (15.8%) with preoperative brachytherapy but no significant difference. Exclusive surgery is probably preferable for the patient's quality of life.
PMID: 25986397 [PubMed - in process]
Source: Gynecologie Obstetrique Fertilite - Category: OBGYN Tags: Gynecol Obstet Fertil Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | OBGYN | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology